2014
DOI: 10.1007/s11934-014-0420-7
|View full text |Cite
|
Sign up to set email alerts
|

Implications of the New AUA Guidelines on Prostate Cancer Detection in the U.S.

Abstract: In 2012, the U.S. Preventive Services Task Force (USPSTF) issued a blanket "D" recommendation against all prostate-specific antigen (PSA)-based early detection efforts for prostate cancer, reflecting critical misinterpretations of the major evidence regarding benefits and harms of such testing. Against the backdrop of the ensuing controversy, in 2013 the American Urological Association (AUA) published a new, methodologically rigorous guideline. This guideline recommended that men aged 55-69 be offered biennial… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
15
0

Year Published

2015
2015
2024
2024

Publication Types

Select...
6
2

Relationship

1
7

Authors

Journals

citations
Cited by 21 publications
(15 citation statements)
references
References 49 publications
0
15
0
Order By: Relevance
“…44,45 A major argument by the USPSTF was that the PLCO trial failed to demonstrate a significant reduction in prostate cancer mortality in the screened group compared with the control group; however, a critical flaw of the PLCO trial was that it was not a true comparison between a screened population and an unscreened population. Before the study, 44% of all enrollees, regardless of whether they were randomized ultimately into the screening group or the control group, had at least 1 PSA test before enrollment.…”
Section: Key Points On Clinical Outcomesmentioning
confidence: 99%
“…44,45 A major argument by the USPSTF was that the PLCO trial failed to demonstrate a significant reduction in prostate cancer mortality in the screened group compared with the control group; however, a critical flaw of the PLCO trial was that it was not a true comparison between a screened population and an unscreened population. Before the study, 44% of all enrollees, regardless of whether they were randomized ultimately into the screening group or the control group, had at least 1 PSA test before enrollment.…”
Section: Key Points On Clinical Outcomesmentioning
confidence: 99%
“…10 However, this blanket recommendation has not been without controversy, given the nuances of trial design, population characteristics, and subanalyses of what to our knowledge are the 2 most methodologically sound studies of PSA screening to date (the Prostate, Lung, Colorectal and Ovarian [PLCO] Cancer Screening Trial and European Randomized Study of Screening for Prostate Cancer ERPC). [11][12][13] In addition, worries regarding an increase in avoidable cancer deaths in the absence of screening remain. 14 Nevertheless, the current paradigm is to avoid overtreatment simply by screening no one.…”
Section: Prostate-specific Antigen Screeningmentioning
confidence: 99%
“…These issues are why, in part, the US Preventive Services Task Force determined PSA screening to be a grade D recommendation, stating that the risks of screening outweigh the benefits . However, this blanket recommendation has not been without controversy, given the nuances of trial design, population characteristics, and subanalyses of what to our knowledge are the 2 most methodologically sound studies of PSA screening to date (the Prostate, Lung, Colorectal and Ovarian [PLCO] Cancer Screening Trial and European Randomized Study of Screening for Prostate Cancer ERPC) . In addition, worries regarding an increase in avoidable cancer deaths in the absence of screening remain .…”
Section: Introductionmentioning
confidence: 99%
“…1 Current US guidelines recommend observational management, AS or watchful waiting (WW), as strategies for men who are at low-risk of disease progression, 24 thereby avoiding active treatment (AT) unless clinical measures indicate disease progression or the patient requests AT. 5, 6 Results from prostate-specific antigen (PSA) testing and repeat biopsies are used to determine PCa progression and prompt cessation of observational management.…”
Section: Introductionmentioning
confidence: 99%